False-positive Xpert^® Xpress SARS-CoV-2 assay in an emergency room and trauma center

References

1. 1.↵
   1. Dong X,
   2. Liu L,
   3. Tu Y,
   4. Zhang J,
   5. Miao G,
   6. Zhang L, et al.

   Rapid PCR powered by microfluidics: a quick review under the background of COVID-19 pandemic. Trends Analyt Chem 2021; 143: 116377.

   OpenUrl
2. 2.↵
   1. Das R,
   2. Joshi S,
   3. Pednekar S,
   4. Karyakarte R

   . Comparison of Xpert Xpress SARS-CoV-2 assay and RT-PCR test in diagnosis of COVID-19. IOSR J Dent Med Sci 2021; 20: 12–17.

   OpenUrl
3. 3.↵
   1. Mouliou DS,
   2. Gourgoulianis KI

   . False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives. Expert Rev Respir Med 2021; 15: 993–1002.

   OpenUrlPubMed
4. 4.↵
   1. Healy B,
   2. Khan A,
   3. Metezai H,
   4. Blyth I,
   5. Asad H

   . The impact of false positive COVID-19 results in an area of low prevalence. Clin Med (Lond) 2021; 21: e54–e56.

   OpenUrl
5. 5.↵
   1. Kim TY,
   2. Kim JY,
   3. Shim HJ,
   4. Yun SA,
   5. Jang JH,
   6. Huh HJ, et al.

   Performance evaluation of the PowerChek SARS-CoV-2, influenza A & B multiplex real-time PCR kit in comparison with the BioFire respiratory panel. Ann Lab Med 2022; 42: 473–477.

   OpenUrl
6. 6.↵
   1. May L,
   2. Tran N,
   3. Ledeboer NA

   . Point-of-care COVID-19 testing in the emergency department: current status and future prospects. Expert Rev Mol Diagn 2021; 21: 1333–1340.

   OpenUrl
7. 7.↵
   Cepheid. Xpert^® Xpress SARS-CoV-2 instructions for use. [Updated 2021; 2022 Apr 4]. Available from: https://www.fda.gov/media/136314/download
8. 8.↵
   1. Dinnes J,
   2. Deeks JJ,
   3. Adriano A,
   4. Berhane S,
   5. Davenport C,
   6. Dittrich S, et al.

   Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2020; 8: CD013705.
9. 9.↵
   Korean Centers for Disease Control and Prevention. Past updates on the COVID-19 (February 25, 2022). [Updated 2022; Cited 2022 Apr 4]. Available from: http://ncov.mohw.go.kr/tcmBoardView.do?brdId=3&brdGubun=31&dataGubun=&ncvContSeq=6420&contSeq=6420&board_id=312&gubun=ALL
10. 10.↵
    1. Lee HJ,
    2. Park OK,
    3. Park JS,
    4. Park DB,
    5. Seo MG,
    6. Kim H, et al.

    Analysis of testing results on temporary testing stations for COVID-19 in the Seoul Metropolitan Area, 2020-2021. Public Health Weekly Rep 2021; 14: 3610–3613.

    OpenUrl
11. 11.↵
    Korean Centers for Disease Control and Prevention. Findings from investigation and analysis of re-positive cases. [Updated 2020; 2022 Apr 4]. Available from: https://www.mofa.go.kr/eng/brd/m_22743/view.do?seq=3&srchFr=&srchTo=&srchWord=&srchTp=&multi_itm_seq=0&itm_seq_1=0&itm_seq_2=0&company_cd=&company_nm=&page=1&titleNm=
12. 12.↵
    1. Xing Y,
    2. Mo P,
    3. Xiao Y,
    4. Zhao O,
    5. Zhang Y,
    6. Wang F

    . Post-discharge surveillance and positive virus detection in 2 medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. Euro Surveill 2020; 25: 2000191.

    OpenUrl
13. 13.↵
    1. Kang YJ

    . South Korea’s COVID-19 infection status: from the perspective of re-positive test results after viral clearance evidenced by negative test results. Disaster Med Public Health Prep 2020; 14: 762–764.

    OpenUrl
14. 14.↵
    Korean Centers for Disease Control and Prevention. Korean government’s COVID-19 response guideline (12th edition). [Updated 2022; 2022 Apr 4]. Available from: http://ncov.mohw.go.kr/shBoardView.do?brdId=2&brdGubun=23&ncvContSeq=6413
15. 15.↵
    1. Kahn M,
    2. Schuierer L,
    3. Bartenschlager C,
    4. Zellmer S,
    5. Frey R,
    6. Freitag M, et al.

    Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests. BMC Infect Dis 2021; 21: 798.

    OpenUrl